Related Experiment Videos
Dynamic infrared imaging for the detection of malignancy
Terry M Button1, Haifang Li, Paul Fisher
1Department of Radiology, State University of New York at Stony Brook, Stony Brook, NY 11794, USA. tbutton@radiol.som.sunysb.edu
Physics in Medicine and Biology
|September 11, 2004
Summary
Dynamic infrared imaging (DIRI) detects malignancy by visualizing tumor-induced vasodilation via nitric oxide (NO). This non-invasive technique shows promise for early cancer detection, including breast cancer.
Area of Science:
- Biomedical Imaging
- Cancer Research
- Physiology
Background:
- Malignancy detection remains a critical challenge in healthcare.
- Dynamic infrared imaging (DIRI) offers a novel, non-invasive approach to visualize physiological changes associated with tumors.
- Nitric oxide (NO) plays a role in tumor-associated vasodilation.
Purpose of the Study:
- To investigate the potential of DIRI for malignancy detection in an animal model.
- To validate DIRI's ability to detect vasomotor and cardiogenic surface perfusion in human subjects.
- To explore the application of DIRI for breast cancer detection.
Main Methods:
- DIRI was used to image tumor-bearing mice, observing patterns at vasomotor and cardiogenic frequencies.
- Agents blocking or producing nitric oxide (NO) were administered to assess their effect on DIRI signals.
- DIRI measurements in human subjects were compared with laser Doppler flowmetry (LDF) for validation.
- DIRI was applied to differentiate between normal and malignant breast tissue.
Main Results:
- Malignancy was identifiable in DIRI images of tumor-bearing mice through specific vasomotor and cardiogenic frequency patterns.
- The observed malignancy patterns were abolished by blocking NO-induced vasodilation and mimicked by NO-producing agents in normal mice.
- DIRI successfully validated vasomotor and cardiogenic surface perfusion detection against LDF in humans.
- Distinct image pattern differences were observed between normal and malignant breast tissue using DIRI.
Conclusions:
- DIRI can detect malignancy in an animal model by identifying NO-mediated vasodilation.
- DIRI technology is validated for assessing surface perfusion in humans.
- DIRI shows potential as a non-invasive tool for breast cancer detection.